Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.

Outlook Therapeutics trims workforce by 23% to fund Lytenava launch

Pallavi Madhiraju- December 14, 2024 0

Outlook Therapeutics, a biopharmaceutical company specialising in retina disease treatments, has announced a 23% workforce reduction as part of strategic cost-saving measures. This move is ... Read More

FDA approves Checkpoint Therapeutics’ Unloxcyt for advanced cSCC

Pallavi Madhiraju- December 14, 2024 0

Shares of Checkpoint Therapeutics, Inc. rose 4.6% to $3.84 in post-market trading after the US Food and Drug Administration (FDA) approved Unloxcyt (cosibelimab-ipdl) treatment for ... Read More

FDA approves CRENESSITY: A breakthrough treatment from Neurocrine Biosciences for classic congenital adrenal hyperplasia

Pallavi Madhiraju- December 14, 2024 0

Neurocrine Biosciences has announced US Food and Drug Administration (FDA) approval of CRENESSITY, marking a significant milestone in the treatment of classic congenital adrenal hyperplasia ... Read More

Merck’s WELIREG receives positive CHMP opinion for VHL tumours and advanced RCC

Pallavi Madhiraju- December 13, 2024 0

Merck, known as MSD outside the U.S. and Canada, has moved a step closer to offering innovative treatment options in Europe. The European Medicines Agency’s ... Read More

Aptevo Therapeutics achieves major breakthrough with mipletamig in acute myeloid leukemia

Pallavi Madhiraju- December 12, 2024 0

Aptevo Therapeutics has unveiled remarkable findings from Cohort 1 of its RAINIER clinical trial for mipletamig, a bispecific antibody aimed at tackling acute myeloid leukemia ... Read More

Trevi Therapeutics announces positive results for Haduvio in Phase 2b CORAL study

Pallavi Madhiraju- December 12, 2024 0

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, has reported a positive outcome from the planned sample size re-estimation (SSRE) for its ongoing Phase 2b trial. ... Read More

Keros Therapeutics adjusts TROPOS trial of cibotercept amid safety concerns

Pallavi Madhiraju- December 12, 2024 0

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced significant changes to its Phase 2 TROPOS trial evaluating cibotercept safety concerns in patients with pulmonary ... Read More

Eli Lilly achieves breakthrough with Imlunestrant in Phase 3 breast cancer trial

Pallavi Madhiraju- December 11, 2024 0

Eli Lilly and Company has announced encouraging results from its Phase 3 EMBER-3 study evaluating imlunestrant, an investigational oral selective estrogen receptor degrader (SERD), for ... Read More

AnaptysBio abandons eczema drug after trial failures; shares nosedive

Pallavi Madhiraju- December 11, 2024 0

Biotechnology company AnaptysBio, Inc., specializing in innovative autoimmune disease therapies, announced it will halt development of its atopic dermatitis treatment, ANB032, after the drug failed ... Read More

UniQure shares surge as FDA aligns on accelerated approval pathway for AMT-130 in Huntington’s disease

Pallavi Madhiraju- December 10, 2024 0

UniQure, Huntington’s disease, gene therapy, FDA, accelerated approval pathway, regenerative medicine designation, AMT-130, Biologics License Application, neurodegenerative diseases, cUHDRS, Phase I/II studies, neurofilament light chain, ... Read More